查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1953405

虛擬實境在治療領域的市場－全球產業規模、佔有率、趨勢、機會及預測（按技術、設備、應用、地區和競爭格局分類，2021-2031年）

Virtual Reality in Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented, By Technology, By Device, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球治療性虛擬實境市場預計將從 2025 年的 33.1 億美元大幅成長至 2031 年的 74.7 億美元，複合年成長率達 14.53%。

此領域利用身臨其境型數位類比技術輔助身體復健、緩解疼痛，並應對焦慮和創傷後壓力症候群（PTSD）等心理健康挑戰。其發展的主要驅動力是慢性病盛行率的上升以及對擴充性、非侵入性治療方法的迫切需求，這些方案能夠減輕傳統醫療系統的負擔。此外，這些身臨其境型工具與遠端醫療基礎設施的日益融合，提高了病患的就醫便利性和參與度，使這項技術成為現代醫療保健體系的關鍵組成部分。

市場概覽
預測期 2027-2031
市場規模：2025年 33.1億美元
市場規模：2031年 74.7億美元
複合年成長率：2026-2031年 14.53%
成長最快的細分市場 半身臨其境型虛擬實境
最大的市場 北美洲

儘管市場呈現上升趨勢，但仍面臨許多挑戰，尤其是採購專用硬體和開發臨床檢驗軟體的高昂成本。這些財務障礙，加上複雜的報銷體系，可能會減緩小規模醫療機構的採用速度。然而，業內人士的信心依然強勁。 XR協會報告稱，84%的醫療專業人士預測，虛擬實境（VR）和擴增實境（AR）技術將在2024年成為推動產業變革的積極力量。這種普遍的樂觀情緒凸顯了身臨其境型治療方法的持久價值，即便麵臨經濟和營運上的挑戰。

市場促進因素

臨床檢驗和監管核准的不斷增加正在從根本上改變市場格局，使虛擬實境技術從輔助手段躍升為公認的醫療干預手段。隨著監管機構制定更清晰的核准流程，醫療專業人員越來越有信心將身臨其境型療法應用於各種用途，從術前準備到疼痛緩解。獲批解決方案數量的不斷成長也印證了這一發展勢頭。根據《放射學商業》（Radiology Business）2024年9月刊報道，美國FDA已核准69種採用擴增實境（AR）或虛擬實境（VR）技術的醫療產品，這標誌著監管環境日趨成熟，將有助於更廣泛地接受這些技術。此類核准對於消除臨床醫生和保險公司的疑慮，並迅速將這些設備納入標準治療通訊協定至關重要。

此外，政府津貼和企業對數位療法的投資激增，正助力企業拓展業務和技術能力，加速市場擴張。這筆資金注入使企業能夠整合資產、擴大臨床覆蓋範圍，並打造先進的人工智慧驅動型個人化醫療功能。例如，根據MedCity News在2024年1月報道，XRHealth公司已成功資金籌措600萬美元，用於與Amelia Virtual Care合併，開發基於人工智慧的臨床醫生，從而建立一個涵蓋身心健康的綜合平台。這筆資金對於進行大規模臨床試驗至關重要，而這些試驗對於驗證療效和獲得醫療保險報銷必不可少。 AppliedVR在2024年發布的報告顯示，70%的嚴重慢性疼痛患者在接受治療後疼痛強度有所減輕，這便是支持這項投資的臨床成功案例，凸顯了這些技術的切實益處。

市場挑戰

治療性虛擬實境市場面臨的主要障礙是部署專用硬體和開發經臨床檢驗的軟體所需的高昂成本。身臨其境型治療應用需要精密的頭戴式顯示器和強大的計算能力，以確保療效和患者安全，這導致前期投入巨大。對於許多獨立診所和小規模醫療機構而言，這些前期投資往往構成障礙，實際上阻礙了他們獲得創新工具。此外，維護和更新複雜的數位基礎設施所需的持續資源也加劇了這種經濟負擔，導致只有資金雄厚的大型機構才能採用此類技術。

因此，這些經濟限制直接限制了虛擬實境療法在整個醫療保健生態系統中廣泛應用的潛力。行業調查也反映了這種投資意願不足的問題。根據XR協會2024年發布的數據，30%的醫療服務提供者表示，他們對實施擴增實境計畫的成本有疑慮。再加上報銷政策不明朗，這種財務上的不確定性減緩了市場滲透，限制了患者獲得身臨其境型療法的機會，並最終阻礙了整個領域的發展。

市場趨勢

透過拓展至兒童和青少年治療領域，市場正實現多元化發展，研發人員正針對弱視等疾病設計針對特定年齡層的介入措施。這項進步滿足了年輕患者獨特的發展需求，並將產業的應用範圍從傳統的成人復健領域擴展到更廣泛的範圍。透過利用身臨其境型和互動式視覺環境，這些療法能夠提高那些難以用標準方法治療的患者群體的治療依從性。 2025年4月，BioSpace宣布Luminopia的虛擬實境療法獲得FDA批准，可用於8至12歲的兒童。這標誌著一個重要的里程碑，為美國約40萬名弱視青少年提供了一種新的治療選擇，並凸顯了該行業致力於拓展臨床應用的決心。

同時，居家和遠端醫療的興起正在改變服務提供方式，使患者在臨床環境之外也能獲得持續的醫療服務。利用雲端頭戴裝置即時追蹤病患病情進展，使得身臨其境型治療擴充性。隨著以使用者為中心的硬體設計不斷進步，在患者家中實施治療方案能夠減輕醫療服務提供者的負擔。根據《XR Today》雜誌（2025年2月刊）報道，XRHealth宣布其平台目前已被超過2,000名臨床醫師採用，並為超過5萬名患者提供支援。這項數據得益於其對居家身臨其境型醫療生態系統的策略性關注。這項發展也印證了遠距VR治療作為標準治療方案的可行性。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球虛擬實境在治療領域的市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術分類（完全身臨其境型VR、半身臨其境型VR、非身臨其境型VR）
    • 依設備類型（頭戴式、手勢控制、投影機）
    • 依應用領域（恐懼症治療、機器人手術、視覺化、復健、創傷後壓力症候群（PTSD）治療、自閉症治療、手術模擬）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美虛擬實境治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲虛擬實境在治療領域的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區虛擬實境在治療領域的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲虛擬實境在治療領域的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲虛擬實境在治療領域的市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球虛擬實境治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Siemens AG
  • Virtalis Holding Limited
  • Vuzix Corporation
  • Elevate Healthcare, Inc.
  • Qualcomm Incorporated
  • Virtual Realities, LLC
  • Brainlab AG
  • Surgical Science Sweden AB

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 25246

The Global Virtual Reality in Therapy Market is projected to expand significantly, rising from a valuation of USD 3.31 Billion in 2025 to USD 7.47 Billion by 2031, reflecting a compound annual growth rate of 14.53%. This sector encompasses the utilization of immersive digital simulations to support physical rehabilitation, alleviate pain, and address mental health challenges like anxiety and PTSD. A primary catalyst for this growth is the escalating prevalence of chronic diseases, coupled with an urgent demand for scalable, non-invasive treatment options that can reduce the strain on conventional medical systems. Additionally, the increasing convergence of these immersive tools with telehealth infrastructures is improving patient accessibility and participation, establishing the technology as a crucial element of contemporary healthcare frameworks.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.31 Billion
Market Size 2031USD 7.47 Billion
CAGR 2026-203114.53%
Fastest Growing SegmentSemi-Immersive VR
Largest MarketNorth America

Despite this upward trajectory, the market faces notable impediments, particularly regarding the substantial expenses linked to procuring specialized hardware and engineering clinically verified software. These financial hurdles, along with complicated reimbursement structures, may retard adoption rates among smaller medical facilities. Nevertheless, confidence within the industry remains strong; the XR Association reported in 2024 that 84 percent of healthcare experts anticipate virtual and augmented reality technologies will effect a positive transformation within the sector. This pervasive optimism highlights the enduring value of immersive therapeutics, even amidst prevailing economic and operational challenges.

Market Driver

The market is being fundamentally transformed by an increase in clinical validations and regulatory endorsements, which are elevating virtual reality from a supplementary aid to a recognized medical intervention. As regulatory authorities define clearer approval pathways, medical practitioners are acquiring the assurance needed to prescribe immersive therapies for various applications, from surgical preparation to pain relief. This momentum is demonstrated by the growing number of sanctioned solutions; according to Radiology Business in September 2024, the U.S. FDA has authorized 69 medical products utilizing augmented or virtual reality, indicating a mature regulatory landscape that fosters broader acceptance. Such endorsements are essential for dispelling skepticism among clinicians and insurers, thereby hastening the incorporation of these devices into standard treatment protocols.

Furthermore, the surge in government grants and corporate investments in digital therapeutics is accelerating market expansion by enabling enterprises to enlarge their operations and advance their technological prowess. These financial infusions allow companies to combine assets, extend their clinical reach, and create advanced AI-driven capabilities for personalized care. For example, MedCity News reported in January 2024 that XRHealth obtained $6 million to facilitate its merger with Amelia Virtual Care and develop an AI-based clinician, establishing a comprehensive platform for physical and mental health. This capital is vital for running the extensive trials required to demonstrate efficacy and obtain reimbursement. Illustrating the clinical success fueling this investment, AppliedVR noted in 2024 that 70 percent of patients with high-impact chronic pain experienced a reduction in pain severity following treatment, emphasizing the concrete benefits these technologies provide.

Market Challenge

A major obstacle hindering the virtual reality in therapy market is the substantial expense involved in implementing specialized hardware and creating clinically validated software. Immersive therapeutic applications demand sophisticated head-mounted displays and robust computing capabilities to guarantee both effectiveness and patient safety, necessitating considerable initial capital outlays. For numerous independent clinics and smaller healthcare entities, these upfront costs are often prohibitive, effectively blocking access to these innovative tools. This financial burden is exacerbated by the ongoing resources needed to support and upgrade complex digital infrastructures, resulting in a landscape where primarily large, well-resourced institutions can feasibly adopt such technologies.

Consequently, these economic constraints directly limit the scalability of VR therapies throughout the wider healthcare ecosystem. This reluctance to invest is reflected in industry surveys regarding adoption hurdles. According to data from the XR Association in 2024, 30 percent of healthcare professionals cited specific concerns regarding the costs associated with deploying extended reality programs. When combined with ambiguous reimbursement policies, this financial anxiety retards the pace of market penetration and restricts patient access to immersive treatments, ultimately impeding the overall growth of the sector.

Market Trends

The market is diversifying through an expansion into pediatric and adolescent therapy sectors, with developers designing age-specific interventions for conditions such as amblyopia. This progression caters to the distinct developmental requirements of younger patients, extending the industry's reach beyond its traditional emphasis on adult rehabilitation. By leveraging immersive and interactive visual environments, these therapies enhance adherence in demographic groups that are often challenging to treat via standard methods. As reported by BioSpace in April 2025, Luminopia achieved FDA clearance to extend its virtual reality therapy to children between the ages of 8 and 12, a significant milestone that offers a new treatment avenue for roughly 400,000 young patients in the U.S. with amblyopia, highlighting the industry's dedication to broadening its clinical application.

Simultaneously, the shift toward home-based and remote care paradigms is transforming service delivery by facilitating continuous therapy outside of clinical environments. This evolution enables providers to track patient progress in real-time using cloud-enabled headsets, thereby enhancing the scalability of immersive treatments. As hardware becomes increasingly user-centric, the ability to administer therapeutic programs directly in patients' homes alleviates logistical pressures on medical facilities. According to XR Today in February 2025, XRHealth announced that its platform is now employed by over 2,000 clinicians to assist more than 50,000 patients, a statistic resulting from its strategic emphasis on a home-based immersive healthcare ecosystem. This rising utilization underscores the practicality of remote VR therapy as a recognized standard of care.

Key Market Players

  • Siemens AG
  • Virtalis Holding Limited
  • Vuzix Corporation
  • Elevate Healthcare, Inc.
  • Qualcomm Incorporated
  • Virtual Realities, LLC
  • Brainlab AG
  • Surgical Science Sweden AB

Report Scope

In this report, the Global Virtual Reality in Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virtual Reality in Therapy Market, By Technology

  • Full Immersive VR
  • Semi-Immersive VR
  • Non- Immersive VR

Virtual Reality in Therapy Market, By Device

  • Head Mount
  • Gesture Control
  • Projectors

Virtual Reality in Therapy Market, By Application

  • Phobia Treatment
  • Robotic Surgery
  • Visualization
  • Rehabilitation
  • Treatment of Post-Traumatic Stress Disorder
  • Treatment of Autism
  • Surgery Simulation

Virtual Reality in Therapy Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virtual Reality in Therapy Market.

Available Customizations:

Global Virtual Reality in Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virtual Reality in Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Full Immersive VR, Semi-Immersive VR, Non- Immersive VR)
    • 5.2.2. By Device (Head Mount, Gesture Control, Projectors)
    • 5.2.3. By Application (Phobia Treatment, Robotic Surgery, Visualization, Rehabilitation, Treatment of Post-Traumatic Stress Disorder, Treatment of Autism, Surgery Simulation)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Virtual Reality in Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Device
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Virtual Reality in Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Device
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Virtual Reality in Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Device
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Virtual Reality in Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Device
        • 6.3.3.2.3. By Application

7. Europe Virtual Reality in Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Device
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Virtual Reality in Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Device
        • 7.3.1.2.3. By Application
    • 7.3.2. France Virtual Reality in Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Device
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Virtual Reality in Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Device
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Virtual Reality in Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Device
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Virtual Reality in Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Device
        • 7.3.5.2.3. By Application

8. Asia Pacific Virtual Reality in Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Device
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Virtual Reality in Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Device
        • 8.3.1.2.3. By Application
    • 8.3.2. India Virtual Reality in Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Device
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Virtual Reality in Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Device
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Virtual Reality in Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Device
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Virtual Reality in Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Device
        • 8.3.5.2.3. By Application

9. Middle East & Africa Virtual Reality in Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Device
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Virtual Reality in Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Device
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Virtual Reality in Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Device
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Virtual Reality in Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Device
        • 9.3.3.2.3. By Application

10. South America Virtual Reality in Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Device
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Virtual Reality in Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Device
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Virtual Reality in Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Device
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Virtual Reality in Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Device
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Virtual Reality in Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Virtalis Holding Limited
  • 15.3. Vuzix Corporation
  • 15.4. Elevate Healthcare, Inc.
  • 15.5. Qualcomm Incorporated
  • 15.6. Virtual Realities, LLC
  • 15.7. Brainlab AG
  • 15.8. Surgical Science Sweden AB

16. Strategic Recommendations

17. About Us & Disclaimer